Position in PFE
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$5,106,525
-$1,106,540 QoQ
Shares Held
212,065
-4.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#592
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$118,100
PutShares
2,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kingsview Wealth Management, LLC holds $172,226,536 across 14 Drug Manufacturers - General names. PFE ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
82,083 | $98,452,820 | |
| 2 | JNJ |
Johnson & Johnson
|
94,143 | $23,909,497 | |
| 3 | ABBV |
AbbVie Inc.
|
71,689 | $18,039,819 | |
| 4 | MRK |
Merck & Co., Inc.
|
80,440 | $10,336,540 | |
| 5 | AMGN |
Amgen Inc
|
18,729 | $6,782,145 | |
| 6 | PFE |
Pfizer Inc
This page
|
212,065 | $5,106,525 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
45,093 | $2,598,258 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
17,845 | $2,254,537 |
All Filings in PFE
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,106,525 | 212,065 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $6,213,065 | 221,263 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,388,733 | 216,415 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,624,390 | 181,491 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,039,620 | 166,651 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,608,509 | 181,867 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $4,225,724 | 159,281 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $3,577,823 | 123,629 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,266,718 | 295,451 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,537,987 | 91,459 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,816,727 | 97,837 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,647,671 | 109,969 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,806,173 | 103,767 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,272,086 | 104,708 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,489,289 | 107,129 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,256,535 | 97,270 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $4,705,277 | 89,744 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $6,299,114 | 121,675 | Shares | Sole | 2024-02-08 | |
| 2021-12-31 | $6,993,763 | 118,438 | Shares | Sole | 2022-02-17 | |
| 2021-12-31 | $118,100 | 2,000 | Put | Sole | 2022-02-17 | |
| 2021-09-30 | $3,446,477 | 80,132 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $7,832 | 200 | Call | Sole | 2021-08-17 | |
| 2021-06-30 | $3,072,102 | 78,450 | Shares | Sole | 2021-08-17 | |
| 2021-06-30 | $3,916 | 100 | Put | Sole | 2021-08-17 | |
| 2021-03-31 | $2,753,552 | 76,002 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $3,232,838 | 87,825 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $7,362 | 200 | Call | Sole | 2021-02-16 | |
| 2020-09-30 | $2,782,848 | 75,827 | Shares | Sole | 2020-11-19 | |
| 2020-09-30 | $36,699 | 1,000 | Put | Sole | 2020-11-19 | |
| 2020-06-30 | $2,019,652 | 61,763 | Shares | Sole | 2020-08-14 | |
| 2020-06-30 | $6,540 | 200 | Call | Sole | 2020-08-14 | |
| 2020-03-31 | $3,644,577 | 111,660 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||